Research conducted by Prof. HE Mingguang, Director of the Research Centre for SHARP Vision (RCSV) and Chair Professor of Experimental Ophthalmology, has proved that repeated low-level red-light (RLRL) therapy can significantly slow the progression of myopia in children, and can even reverse short-sightedness.
Myopia was considered an irreversible process of axial growth. However, Prof. He found that the axial elongation of children receiving RLRL therapy was 70% less than that of children wearing normal spectacles. Furthermore, multiple clinical studies have demonstrated axial length shortening in up to 40% of RLRL-treated children one month after the therapy.
